Urology Group of New Mexico has been active in providing clinical trials to their patients since 1985. Dr. Snoy serves as the Principal Investigator and employs two certified research coordinators to assist him. The department’s expertise results from over 42 years of combined experience.

Click here to learn more.

 

Address:

4161 Montgomery Blvd. NE

Albuquerque, New Mexico 87109

Phone: 505-872-4091

E-Mail: Click here

Driving Directions: Click here

 

Clinical Trials Information

Clinical research studies are an important part of the development of future medical treatments. The results of research studies are to provide enough information for the governmental regulatory agencies to decide whether to approve new treatments so that doctors may prescribe them for their patients.

To do this, investigational treatments may be compared with the current standard of care, a placebo (inactive drug), or with some other form of treatment.

Participation in a clinical research study is always voluntary, and choosing not to participate will not affect the current medical care that you are receiving.

Deciding whether to participate in a clinical research study is up to you. If you decide not to participate in a clinical research study, your decision will not have any effect on the care you receive now or in the future. If you decide to take part, you may withdraw at any time during the research study. If you have any questions, don’t hesitate to ask the research study staff.

We are here to help you. We can be reached at 505-872-4091 ext. 118 or ext. 117. We can also be emailed at research@ugnm.com or studies@ugnm.com

Current Clinical Trials

Currently, Urology Group of New Mexico is seeking participants who may have:

• Metastatic prostate cancer patients who are currently on Leupron therapy and their PSA’s are still rising.
• Patients that are experiencing frequency and urgency with urination with or without leakage.
• Prostate cancer patients who have had prostatectomies or radiation, but have not yet started hormone therapy. These patients PSA should be between .2 and 1.0.
• Patients with chronic prostatitis with chronic pelvic pain.
• Low libido in female patients who have gone through surgical (have had their ovaries removed) or natural menopause .

 

Additional Clinical Trials Resources

• www.uroweb.org Registration required. Connects to the European Association of Urology. Provides European perspective to urologic problems and additional information.
• www.emergingmed.com This site is dedicated to connecting patients with clinical trials sites.
• www.CBSHealthWatch.com This site connects patients with clinical trials sites and provides all kinds of health information.